Преглед аутора: "Padrón, José M."
Приказ резултата 1-9 од 9
-
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors
Alov, Petko; Al Sharif, Merilin; Aluani, Denitsa; Chegaev, Konstantin; Dinić, Jelena; Divac Rankov, Aleksandra; Fernandes, Miguel X.; Fusi, Fabio; García-Sosa, Alfonso T.; Juvonen, Risto; Kondeva-Burdina, Magdalena; Padrón, José M.; Pajeva, Ilza; Pencheva, Tania; Puerta, Adrián; Raunio, Hannu; Riganti, Chiara; Tsakovska, Ivanka; Tzankova, Virginia; Yordanov, Yordan; Saponara, Simona (Lausanne : Frontiers Media, 2022) -
Biotinylated selenocyanates: Potent and selective cytostatic agents
Roldán-Peña, Jesús M.; Puerta, Adrián; Dinić, Jelena; Jovanović Stojanov, Sofija; González-Bakker, Aday; Hicke, Francisco J.; Mishra, Atreyee; Piyasaengthong, Akkharadet; Maya, Inés; Walton, James W.; Pešić, Milica; Padrón, José M.; Fernández-Bolaños, José G.; López, Óscar (Academic Press Inc., 2023) -
CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić, Jelena; Ríos-Luci, Carla; Karpaviciene, Ieva; Cikotiene, Inga; Fernandes, Miguel X.; Pešić, Milica; Padrón, José M. (Investigational New DrugsInvestigational New Drugs, 2020) -
Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases
Fuentes-Aguilar, Alma; González-Bakker, Aday; Jovanović, Mirna; Jovanović Stojanov, Sofija; Puerta, Adrián; Gargano, Adriana; Dinić, Jelena; Vega-Báez, José L.; Merino-Montiel, Penélope; Montiel-Smith, Sara; Alcaro, Stefano; Nocentini, Alessio; Pešić, Milica; Supuran, Claudiu T.; Padrón, José M.; Fernández-Bolaños, José G.; López, Óscar (Elsevier Inc., 2024) -
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
Podolski-Renić, Ana; Banković, Jasna; Dinić, Jelena; Ríos-Luci, Carla; Fernandes, Miguel X.; Ortega, Nuria; Kovačević-Grujičić, Nataša; Martín, Víctor S.; Padrón, José M.; Pešić, Milica (Amsterdam: Elsevier, 2017) -
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
Podolski-Renić, Ana; Banković, Jasna; Dinić, Jelena; Ríos-Luci, Carla; Fernandes, Miguel X.; Ortega, Nuria; Kovačević-Grujičić, Nataša; Martín, Víctor S.; Padrón, José M.; Pešić, Milica (European Journal of Pharmaceutical Sciences, 2017) -
Repurposing old drugs to fight multidrug resistant cancers
Dinić, Jelena; Efferth, Thomas; García-Sosa, Alfonso T.; Grahovac, Jelena; Padrón, José M.; Pajeva, Ilza; Rizzolio, Flavio; Saponara, Simona; Spengler, Gabriella; Tsakovska, Ivanka (Churchill Livingstone, 2020) -
Repurposing old drugs to fight multidrug resistant cancers
Dinić, Jelena; Efferth, Thomas; García-Sosa, Alfonso T.; Grahovac, Jelena; Padrón, José M.; Pajeva, Ilza; Rizzolio, Flavio; Saponara, Simona; Spengler, Gabriella; Tsakovska, Ivanka (Churchill Livingstone, 2020) -
Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents
Hicke, Francisco; Puerta, Adrián; Dinić, Jelena; Pešić, Milica; Padrón, José M.; López, Óscar; Fernández-Bolaños, José G. (Amsterdam : Elsevier Ltd, 2022)